Active Pharmaceutical Ingredient Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Global

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > Active Pharmaceutical Ingredient Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Active Pharmaceutical Ingredient Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.6% over the next decade to reach approximately $238.7 Billion by 2024. The Active Pharmaceutical Ingredient (API) is the element of any drug that produces its effects. Few drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries.

Global Active Pharmaceutical Ingredients Market Share:

By Type of Synthesis, Synthetic segment holds the largest market share in 2018. By Manufacturer Type, It is classified as captive or in-house and the merchant or outsourced APIs. According to the market estimates, Captive APIs holds the largest segment in 2018 and the merchant APIs are expected to be the fastest-growing segment over the forecast period 2018-20124.By Type, Generics are expected to be the fastest-growing segment type over the forecast period. By Application, Cardiovascular diseases dominated in 2018 owing to its higher prevalence rate and high amount of product availability.

Global Active Pharmaceutical Ingredients Market Size:

North America Active Pharmaceutical Ingredients Market dominated the overall API market in 2018 and is expected to hold its position

Active Pharmaceutical Ingredient Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

over the forecast period, owing to the increasing R&D expenditure, rising favourable government initiatives for usage of generic drugs and technological advancements in the field of drug manufacturing. Asia Pacific is expected to be the fastest-growing API Market over the forecast period owing to the availability of affordable labour.

Global Active Pharmaceutical Ingredients Market Growth:

Increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications and increasing uptake of biopharmaceuticals propel the API market growth.

Global Active Pharmaceutical Ingredients Market Industry Analysis:

The Global Active Pharmaceutical Ingredients (API) market is segmented By Business Mode into captive and merchant Active Pharmaceutical Ingredients ,By Type of Synthesis into synthetic and biotech, By Customer Base into generic and branded ,By Application into cardiology, pulmonology, oncology, ophthalmology, neurology and orthopedics and By Geography into North America, Europe, Asia-pacific, the Middle East & Africa and South America.

Global Active Pharmaceutical Ingredients Market Outlook:

Production of APIs has generally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs. This has caused significant changes

You can also purchase parts of this report. Do you want to check out a section wise price list

Active Pharmaceutical Ingredient Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

to how these drugs are regulated, with more rigorous guidelines and inspections put into place.

Global Active Pharmaceutical Ingredients Market Trends:

Dr Reddy’s Laboratories announces the launch of their new product Melphalan Hydrochloride for Injection in the U.S. Market. Sangamo and Pfizer announce their collaboration for the development of a potential gene therapy using zinc finger protein transcription factors to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.

Global Active Pharmaceutical Ingredients Market Research report includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
Identify the latest developments, market shares and strategies that are employed by the major market players, such as
Pfizer, Inc
Reddy’s Lab
Ranbaxy Laboratories
NovartisAlbemarle Corporation

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.